Drawing for (B)

USPTO serial 87810948

(B)

Reviewed by CopyMark Law Group

Reg. 5634743Status 710
Filing date
Status date
Registration date
Dec 18, 2018
Examiner
FALK, ERIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with (B)?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Marr

DAVID J. MARR CLARK HILL PLC130 E RANDOLPH ST STE 3900CHICAGO, IL 60601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044therapeutic services, namely, intramuscular, intravenous and subcutaneous vitamin and nutrient injections, composed in whole or in substantial part of Vitamin B injectionsSECTION 8 - CANCELLEDFeb 22, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 4, 2025C8..CANCELLED SEC. 8 (6-YR)—
Dec 18, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 18, 2018R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Nov 10, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 7, 2018ALIEASSIGNED TO LIE—
Oct 24, 2018CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Sep 12, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2018DOCKASSIGNED TO EXAMINER—
Mar 15, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance